SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 191.75+1.0%Jan 5 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (8542)10/7/1997 6:50:00 AM
From: Henry Niman   of 32384
 
Andy. Michael Karin who is on the citation list also covers some of the same targets as Ron Evans including heterodimers with RXRs:

Mol Cell Biol 1996 Jan;16(1):219-227

A shift in the ligand responsiveness of thyroid hormone
receptor alpha induced by heterodimerization with
retinoid X receptor alpha.

Claret FX, Antakly T, Karin M, Saatcioglu F

Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla
92093-0636, USA.

Thyroid hormone (T3) receptors (T3Rs) are ligand-modulated transcription factors that bind to
thyroid hormone response elements (T3REs) and mediate either positive or negative transcriptional
regulation of target genes. In addition, in response to ligand binding, T3Rs can interfere with AP-1
activity and thereby inhibit transcription of AP-1-responsive genes. T3Rs were recently shown to
form heterodimers with retinoid X receptors (RXRs), leading to increased binding to T3REs in vitro
and potentiation of transcriptional responses in vivo. Here we demonstrate that T3R alpha forms
stable heterodimers with RXR alpha in living cells. Most important, we describe a new role for RXR
alpha in modulating ligand-dependent T3R alpha activity: heterodimerization with RXR alpha greatly
increases transcriptional interference with AP-1 activity, augments T3-dependent transcriptional
activation, and potentiates the reversal of ligand-independent activation by T3R alpha. In all three
cases, the responses occur at substantially lower T3 concentrations when elicited by T3R alpha plus
RXR alpha than by T3R alpha alone. In vitro, the binding of T3 decreases the DNA-binding activity
of T3R alpha homodimers but does not affect DNA binding by T3R alpha:RXR alpha heterodimers.
We provide evidence that increased activities of T3R alpha at lower T3 concentrations are not due
to changes in its T3 binding properties. Instead, the altered response could be mediated by either
RXR alpha-induced conformational changes, increased stability of heterodimers over homodimers,
especially following T3 binding, or both.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext